An indirect two-site binding enzyme immunoassay (EIA) is described, in which horse-radish peroxidase (HRP) is bound immunologically to anti-HRP IgG in the form of peroxidase anti-peroxidase complexes (PAP-complex). In this EIA both purified HRP and crude HRP had the same sensitivity due to the selective reaction of the monospecific anti-HRP IgG with the highly active HRP isoenzymes in both preparations. To obtain similar results the amount of crude HRP needed is 18 times higher than that of purified HRP. A comparison of differently composed PAP-complexes showed that only those formed in an excess of HRP yielded a highly sensitive EIA. Urea splitting of the PAP-complexes did not raise the specific activity of the enzyme. The PAP-complexes were used in an assay for quantification of the pregnancy-associated alpha 2-glycoprotein and compared with an indirect two-site binding EIA, in which purified HRP was covalently bound to IgG. Both test variants resulted in the same sensitivity and showed similar precision.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0009-8981(83)90206-1DOI Listing

Publication Analysis

Top Keywords

two-site binding
12
purified hrp
12
peroxidase anti-peroxidase
8
binding enzyme
8
enzyme immunoassay
8
indirect two-site
8
hrp
8
anti-hrp igg
8
eia purified
8
crude hrp
8

Similar Publications

3-Halo-3-nitro-aza/thioflavanones: DNMT inhibitors with a two-site binding mode in the hDNMT3A catalytic pocket.

Bioorg Med Chem

November 2024

Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS-Université de Montpellier-ENSCM, 1919 route de Mende, 34296 Montpellier cedex 5, France. Electronic address:

Flavonoid derivatives are natural product analogues that have shown great interest for therapeutic applications as modulators of DNA methylation. In this article we report new synthesis pathways to access ten novel flavonoid derivatives (i.e.

View Article and Find Full Text PDF

Structural basis for full-length chemerin recognition and signaling through chemerin receptor 1.

Commun Biol

November 2024

Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen, 518172, Guangdong, China.

Chemerin, a chemotactic adipokine, plays essential roles in adipogenesis and inflammation. Serum chemerin concentration is closely associated with obesity and metabolism disorders. The mature form of chemerin (residues 21-157) acts primarily through chemerin receptor 1 (CMKLR1) for transmembrane signaling.

View Article and Find Full Text PDF

Chemerin is an adipokine with chemotactic activity to a subset of leukocytes. Chemerin binds to 3 G protein-coupled receptors, including chemokine-like receptor 1 (CMKLR1), G protein-coupled receptor 1 (GPR1), and C-C chemokine receptor-like 2 (CCRL2). Here, we report that GPR1 is capable of Gi signaling when stimulated with full-length chemerin or its C-terminal nonapeptide (C9, YFPGQFAFS).

View Article and Find Full Text PDF

Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics.

Eur J Med Chem

December 2024

Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden; Lund University Cancer Centre (LUCC), Lund University, Lund, Sweden. Electronic address:

Antibody radionuclide conjugates are an emerging modality for targeted imaging and potent therapy of disseminated disease. Coupling of radionuclides to monoclonal antibodies (mAbs) is typically achieved by applying non-site-specific labelling techniques. With the ambition of reducing variability, increasing labelling efficacy and stability, several site-specific conjugation strategies have been developed in recent years for toxin- and fluorophore-mAb conjugates.

View Article and Find Full Text PDF

Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition.

Proc Natl Acad Sci U S A

October 2024

Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China.

Article Synopsis
  • KSHV is a virus that causes Kaposi's sarcoma and it has a special protein called KSHV-GPCR that helps it avoid our immune system.
  • Scientists studied how KSHV-GPCR works both when a chemokine (like CXCL1) sticks to it and when it works on its own.
  • Their research might help create new ways to treat infections caused by KSHV in the future.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!